LAPELGA
LAPELGA
Approved
DIN Number
02529343
Drug Class
Human
Market Date
Nov 28, 2022
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02529343
AIG Number0149962001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L03AA13 PEGFILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEGFILGRASTIMActive
Strength: 6 MG / 0.6 ML
Monograph: PEGFILGRASTIM